FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2977796475> ?p ?o ?g. }

• W2977796475 endingPage "311" @default.
• W2977796475 startingPage "297" @default.
• W2977796475 abstract "To evaluate the effectiveness of an Avatar application for educating people with acute coronary syndrome (heart attack). A lack of understanding of Acute Coronary Syndrome symptoms and appropriate responses often contribute to delay in seeking medical treatment. A single-centre, non-blinded, pragmatic randomized controlled trial. Seventy Acute Coronary Syndrome patients were randomly assigned to the intervention (Avatar application) or usual care groups. Participants were followed up at 0, 1, and 6 months. Tobit Growth Curve Model was used to analyse the primary outcome—symptom knowledge; and the secondary outcomes—attitudes and beliefs. Heart attack action plan implementation and health care utilisation were analysed using Chi-square and Mann–Whitney U test. Of the 70 participants, 63% were male and the mean age of the participants was 64.7 (SD 11.7) years. Sixty-six (94.2%) participants completed follow-up. Between group differences on acute coronary syndrome (ACS) Response Index scores were statistically significant at 1-month and 6-month follow-ups (p < .01). The intervention group had a significant improvement in symptom knowledge, attitudes, and beliefs over the 6-month period (p < .001, p = .009, p < .001 respectively); and no significant improvement in the usual care group participants (p = .152, p = .068, p = .228). For healthcare use, at follow-up, there was a significant difference in ambulance use, between the intervention group and the usual care group (33.33% vs. 18.18%, p = .008; cardiac: 88.89% vs. 42.86%; p = .049); 85.14% of participants reported that the application helped them to feel more confident in recognizing and responding to symptoms in the future. The education app was effective in improving individuals’ ACS knowledge, attitudes, and beliefs. A large multi-centre trial with a longer follow-up to evaluate the intervention's effectiveness on clinical outcomes will be our next step in evaluation. The content of AVATARS (Nurse Cora) app can be translated into different languages and evaluated for patients from different health settings and linguistic backgrounds. Trial Registration: This study has been registered with Australian New Zealand Clinical Trials Registry (ANZCTR). The trial registration number is ACTRN12616000803493. 将70位急性冠状动脉综合征患者随机分为干预组(Avatar应用组)或常规护理组。分别在0、1和6个月内随访试验参与者。采用Tobit生长曲线模型来对症状知识进行初级结果分析;其次是对态度和信念进行2次结果分析。使用China - square和Mann-Whitney U测试分析心脏病发作行动计划的实施和卫生保健的使用情况。 在70名参与者中,63%为男性,平均年龄为64.7岁(SD 11.7)。66名(94.2%)参与者完成了随访。根据1个月到6个月的跟踪访问,因为不同组间的急性冠状动脉综合征(ACS)的不同,反应指数评分统计数据也大有不同 (p < .01)。干预组在6个月内症状知识、态度和信念有显著提高(p < .001, p = .009, p < .001);常规护理组参与者无明显提高(p = .152, p = .068,p = .228)。在使用医疗服务方面,干预组和常规护理组在使用救护车方面有显著差异(33.33% vs.18.18%, p = .008;心脏:88.89% vs. 42.86%;p = .049);85.14%的参与者表示,该应用帮助他们在未来识别和应对症状时更有信心。 教育应用程序能帮助有效提高ACS患者的知识、态度和信念。我们下一步的评估工作将是一项大型多中心试验,随访时间更长,以评估干预措施对临床结果的有效性。 AVATARS (Nurse Cora)应用程序的内容可以被翻译成不同的语言,并为来自不同健康环境和语言背景的患者评估病情。 本研究已在澳大利亚-新西兰临床试验注册中心(ANZCTR)注册。试验注册号为ACTRN12616000803493。 No conflict of interest has been declared by the author(s)." @default.
• W2977796475 created "2019-10-10" @default.
• W2977796475 creator A5020509741 @default.
• W2977796475 creator A5036812694 @default.
• W2977796475 creator A5088129219 @default.
• W2977796475 creator A5091020213 @default.
• W2977796475 date "2019-11-17" @default.
• W2977796475 modified "2023-10-16" @default.
• W2977796475 title "Effectiveness of an Avatar application for teaching heart attack recognition and response: A pragmatic randomized control trial" @default.
• W2977796475 cites W1834857350 @default.
• W2977796475 cites W1975092865 @default.
• W2977796475 cites W1975209336 @default.
• W2977796475 cites W1982943047 @default.
• W2977796475 cites W2005840334 @default.
• W2977796475 cites W2006078634 @default.
• W2977796475 cites W2016699271 @default.
• W2977796475 cites W2029421509 @default.
• W2977796475 cites W2030589583 @default.
• W2977796475 cites W2033292974 @default.
• W2977796475 cites W2033381314 @default.
• W2977796475 cites W2038287973 @default.
• W2977796475 cites W2040628880 @default.
• W2977796475 cites W2053033463 @default.
• W2977796475 cites W2053888824 @default.
• W2977796475 cites W2056475529 @default.
• W2977796475 cites W2061623382 @default.
• W2977796475 cites W2063166601 @default.
• W2977796475 cites W2064701277 @default.
• W2977796475 cites W2074545043 @default.
• W2977796475 cites W2085508623 @default.
• W2977796475 cites W2088412175 @default.
• W2977796475 cites W2088740621 @default.
• W2977796475 cites W2091979645 @default.
• W2977796475 cites W2100220658 @default.
• W2977796475 cites W2100342205 @default.
• W2977796475 cites W2102362452 @default.
• W2977796475 cites W2108696783 @default.
• W2977796475 cites W2115003519 @default.
• W2977796475 cites W2116945613 @default.
• W2977796475 cites W2117366203 @default.
• W2977796475 cites W2117999649 @default.
• W2977796475 cites W2127670579 @default.
• W2977796475 cites W2134947937 @default.
• W2977796475 cites W2149011208 @default.
• W2977796475 cites W2149771063 @default.
• W2977796475 cites W2156235566 @default.
• W2977796475 cites W2159251035 @default.
• W2977796475 cites W2162364378 @default.
• W2977796475 cites W2167506898 @default.
• W2977796475 cites W2169718958 @default.
• W2977796475 cites W2171894139 @default.
• W2977796475 cites W2184155438 @default.
• W2977796475 cites W2188579124 @default.
• W2977796475 cites W2286791427 @default.
• W2977796475 cites W2324956130 @default.
• W2977796475 cites W2338823291 @default.
• W2977796475 cites W2401021171 @default.
• W2977796475 cites W2416750545 @default.
• W2977796475 cites W2426939834 @default.
• W2977796475 cites W2485948232 @default.
• W2977796475 cites W2554786048 @default.
• W2977796475 cites W2560428474 @default.
• W2977796475 cites W2588888555 @default.
• W2977796475 cites W2594156757 @default.
• W2977796475 cites W2768582063 @default.
• W2977796475 cites W2768927213 @default.
• W2977796475 cites W2780562795 @default.
• W2977796475 cites W2794105832 @default.
• W2977796475 cites W2803382068 @default.
• W2977796475 cites W2809266586 @default.
• W2977796475 doi "https://doi.org/10.1111/jan.14210" @default.
• W2977796475 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31566810" @default.
• W2977796475 hasPublicationYear "2019" @default.
• W2977796475 type Work @default.
• W2977796475 sameAs 2977796475 @default.
• W2977796475 citedByCount "13" @default.
• W2977796475 countsByYear W29777964752020 @default.
• W2977796475 countsByYear W29777964752021 @default.
• W2977796475 countsByYear W29777964752022 @default.
• W2977796475 countsByYear W29777964752023 @default.
• W2977796475 crossrefType "journal-article" @default.
• W2977796475 hasAuthorship W2977796475A5020509741 @default.
• W2977796475 hasAuthorship W2977796475A5036812694 @default.
• W2977796475 hasAuthorship W2977796475A5088129219 @default.
• W2977796475 hasAuthorship W2977796475A5091020213 @default.
• W2977796475 hasBestOaLocation W29777964751 @default.
• W2977796475 hasConcept C126322002 @default.
• W2977796475 hasConcept C12868164 @default.
• W2977796475 hasConcept C159110408 @default.
• W2977796475 hasConcept C168563851 @default.
• W2977796475 hasConcept C1862650 @default.
• W2977796475 hasConcept C2777698277 @default.
• W2977796475 hasConcept C2780665704 @default.
• W2977796475 hasConcept C500558357 @default.
• W2977796475 hasConcept C71924100 @default.
• W2977796475 hasConceptScore W2977796475C126322002 @default.
• W2977796475 hasConceptScore W2977796475C12868164 @default.
• W2977796475 hasConceptScore W2977796475C159110408 @default.

• next